HCPCS Level II · 589 active codes
Q codes: Miscellaneous services (temporary codes)
- Q0035Cardiokymography
- Q0081Infusion therapy, using other than chemotherapeutic drugs, per visit
- Q0083Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit
- Q0084Chemotherapy administration by infusion technique only, per visit
- Q0085Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit
- Q0091Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory
- Q0092Set-up portable x-ray equipment
- Q0111Wet mounts, including preparations of vaginal, cervical or skin specimens
- Q0112All potassium hydroxide (koh) preparations
- Q0113Pinworm examinations
- Q0114Fern test
- Q0115Post-coital direct, qualitative examinations of vaginal or cervical mucous
- Q0138Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
- Q0139Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
- Q0144Azithromycin dihydrate, oral, capsules/powder, 1 gram
- Q0155Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0161Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0162Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0163Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
- Q0164Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0166Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
- Q0167Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0169Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0173Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0174Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0175Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0177Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0180Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
- Q0181Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Q0220Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg
- Q0221Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg
- Q0222Injection, bebtelovimab, 175 mg
- Q0224Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg
- Q0234Injection, tocilizumab-bavi, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation only, 1 mg
- Q0235Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg
- Q0237Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
- Q0238Injection, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
- Q0239Injection, bamlanivimab-xxxx, 700 mg
- Q0240Injection, casirivimab and imdevimab, 600 mg
- Q0243Injection, casirivimab and imdevimab, 2400 mg
- Q0244Injection, casirivimab and imdevimab, 1200 mg
- Q0245Injection, bamlanivimab and etesevimab, 2100 mg
- Q0247Injection, sotrovimab, 500 mg
- Q0249Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
- Q0477Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0478Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type
- Q0479Power module for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0480Driver for use with pneumatic ventricular assist device, replacement only
- Q0481Microprocessor control unit for use with electric ventricular assist device, replacement only
- Q0482Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only
- Q0483Monitor/display module for use with electric ventricular assist device, replacement only
- Q0484Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0485Monitor control cable for use with electric ventricular assist device, replacement only
- Q0486Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only
- Q0487Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only
- Q0488Power pack base for use with electric ventricular assist device, replacement only
- Q0489Power pack base for use with electric/pneumatic ventricular assist device, replacement only
- Q0490Emergency power source for use with electric ventricular assist device, replacement only
- Q0491Emergency power source for use with electric/pneumatic ventricular assist device, replacement only
- Q0492Emergency power supply cable for use with electric ventricular assist device, replacement only
- Q0493Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only
- Q0494Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0495Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0496Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0497Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0498Holster for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0499Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only
- Q0500Filters for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0501Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0502Mobility cart for pneumatic ventricular assist device, replacement only
- Q0503Battery for pneumatic ventricular assist device, replacement only, each
- Q0504Power adapter for pneumatic ventricular assist device, replacement only, vehicle type
- Q0506Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0507Miscellaneous supply or accessory for use with an external ventricular assist device
- Q0508Miscellaneous supply or accessory for use with an implanted ventricular assist device
- Q0509Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
- Q0510Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
- Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
- Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
- Q0513Pharmacy dispensing fee for inhalation drug(s); per 30 days
- Q0514Pharmacy dispensing fee for inhalation drug(s); per 90 days
- Q0515Injection, sermorelin acetate, 1 microgram
- Q0516Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days
- Q0517Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days
- Q0518Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days
- Q0519Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days
- Q0520Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days
- Q0521Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
- Q1004New technology intraocular lens category 4 as defined in federal register notice
- Q1005New technology intraocular lens category 5 as defined in federal register notice
- Q2004Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
- Q2009Injection, fosphenytoin, 50 mg phenytoin equivalent
- Q2017Injection, teniposide, 50 mg
- Q2026Injection, radiesse, 0.1 ml
- Q2028Injection, sculptra, 0.5 mg
- Q2034Influenza virus vaccine, split virus, for intramuscular use (agriflu)
- Q2035Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)
- Q2036Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
- Q2037Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)
- Q2038Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
- Q2039Influenza virus vaccine, not otherwise specified
- Q2040Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
- Q2041Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2042Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2043Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
- Q2049Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
- Q2050Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
- Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)
- Q2053Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2054Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2055Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2056Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2057Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2058Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
- Q3001Radioelements for brachytherapy, any type, each
- Q3014Telehealth originating site facility fee
- Q3027Injection, interferon beta-1a, 1 mcg for intramuscular use
- Q3028Injection, interferon beta-1a, 1 mcg for subcutaneous use
- Q3031Collagen skin test
- Q4001Casting supplies, body cast adult, with or without head, plaster
- Q4002Cast supplies, body cast adult, with or without head, fiberglass
- Q4003Cast supplies, shoulder cast, adult (11 years +), plaster
- Q4004Cast supplies, shoulder cast, adult (11 years +), fiberglass
- Q4005Cast supplies, long arm cast, adult (11 years +), plaster
- Q4006Cast supplies, long arm cast, adult (11 years +), fiberglass
- Q4007Cast supplies, long arm cast, pediatric (0-10 years), plaster
- Q4008Cast supplies, long arm cast, pediatric (0-10 years), fiberglass
- Q4009Cast supplies, short arm cast, adult (11 years +), plaster
- Q4010Cast supplies, short arm cast, adult (11 years +), fiberglass
- Q4011Cast supplies, short arm cast, pediatric (0-10 years), plaster
- Q4012Cast supplies, short arm cast, pediatric (0-10 years), fiberglass
- Q4013Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster
- Q4014Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass
- Q4015Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster
- Q4016Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass
- Q4017Cast supplies, long arm splint, adult (11 years +), plaster
- Q4018Cast supplies, long arm splint, adult (11 years +), fiberglass
- Q4019Cast supplies, long arm splint, pediatric (0-10 years), plaster
- Q4020Cast supplies, long arm splint, pediatric (0-10 years), fiberglass
- Q4021Cast supplies, short arm splint, adult (11 years +), plaster
- Q4022Cast supplies, short arm splint, adult (11 years +), fiberglass
- Q4023Cast supplies, short arm splint, pediatric (0-10 years), plaster
- Q4024Cast supplies, short arm splint, pediatric (0-10 years), fiberglass
- Q4025Cast supplies, hip spica (one or both legs), adult (11 years +), plaster
- Q4026Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass
- Q4027Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster
- Q4028Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass
- Q4029Cast supplies, long leg cast, adult (11 years +), plaster
- Q4030Cast supplies, long leg cast, adult (11 years +), fiberglass
- Q4031Cast supplies, long leg cast, pediatric (0-10 years), plaster
- Q4032Cast supplies, long leg cast, pediatric (0-10 years), fiberglass
- Q4033Cast supplies, long leg cylinder cast, adult (11 years +), plaster
- Q4034Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass
- Q4035Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster
- Q4036Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass
- Q4037Cast supplies, short leg cast, adult (11 years +), plaster
- Q4038Cast supplies, short leg cast, adult (11 years +), fiberglass
- Q4039Cast supplies, short leg cast, pediatric (0-10 years), plaster
- Q4040Cast supplies, short leg cast, pediatric (0-10 years), fiberglass
- Q4041Cast supplies, long leg splint, adult (11 years +), plaster
- Q4042Cast supplies, long leg splint, adult (11 years +), fiberglass
- Q4043Cast supplies, long leg splint, pediatric (0-10 years), plaster
- Q4044Cast supplies, long leg splint, pediatric (0-10 years), fiberglass
- Q4045Cast supplies, short leg splint, adult (11 years +), plaster
- Q4046Cast supplies, short leg splint, adult (11 years +), fiberglass
- Q4047Cast supplies, short leg splint, pediatric (0-10 years), plaster
- Q4048Cast supplies, short leg splint, pediatric (0-10 years), fiberglass
- Q4049Finger splint, static
- Q4050Cast supplies, for unlisted types and materials of casts
- Q4051Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)
- Q4074Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
- Q4081Injection, epoetin alfa, 100 units (for esrd on dialysis)
- Q4082Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)
- Q4100Skin substitute, not otherwise specified
- Q4101Apligraf, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4102Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4103Oasis burn matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4104Integra bilayer matrix wound dressing (bmwd), per square centimeter (add-on, list separately in addition to primary procedure)
- Q4105Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4106Dermagraft, per square centimeter
- Q4107Graftjacket, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4108Integra matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4110Primatrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4111Gammagraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4112Cymetra, injectable, 1 cc
- Q4113Graftjacket xpress, injectable, 1 cc
- Q4114Integra flowable wound matrix, injectable, 1 cc
- Q4115Alloskin, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4116Alloderm, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4117Hyalomatrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4118Matristem micromatrix, 1 mg
- Q4119Matristem wound matrix, per square centimeter
- Q4120Matristem burn matrix, per square centimeter
- Q4121Theraskin, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4122Dermacell, dermacell awm or dermacell awm porous, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4123Alloskin rt, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4124Oasis ultra tri-layer wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4125Arthroflex, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4126Memoderm, dermaspan, tranzgraft or integuply, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4127Talymed, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4128Flex hd, or allopatch hd, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4129Unite biomatrix, per square centimeter
- Q4130Strattice tm, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4131Epifix or epicord, per square centimeter
- Q4132Grafix core and grafixpl core, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4133Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4134Hmatrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4135Mediskin, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4136Ez-derm, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4137Amnioexcel, amnioexcel plus or biodexcel, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4138Biodfence dryflex, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4139Amniomatrix or biodmatrix, injectable, 1 cc
- Q4140Biodfence, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4141Alloskin ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4142Xcm biologic tissue matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4143Repriza, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4145Epifix, injectable, 1 mg
- Q4146Tensix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4147Architect, architect px, or architect fx, extracellular matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4148Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4149Excellagen, 0.1 cc
- Q4150Allowrap ds or dry, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4151Amnioband or guardian, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4152Dermapure, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4153Dermavest and plurivest, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4154Biovance, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4155Neoxflo or clarixflo, 1 mg
- Q4156Neox 100 or clarix 100, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4157Revitalon, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4158Kerecis omega3, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4159Affinity, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4160Nushield, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4161Bio-connekt wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4162Woundex flow, bioskin flow, 0.5 cc
- Q4163Woundex, bioskin, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4164Helicoll, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4165Keramatrix or kerasorb, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4166Cytal, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4167Truskin, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4168Amnioband, 1 mg
- Q4169Artacent wound, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4170Cygnus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4171Interfyl, 1 mg
- Q4172Puraply or puraply am, per square centimeter
- Q4173Palingen or palingen xplus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4174Palingen or promatrx, 0.36 mg per 0.25 cc
- Q4175Miroderm, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4176Neopatch or therion, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4177Floweramnioflo, 0.1 cc
- Q4178Floweramniopatch, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4179Flowerderm, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4180Revita, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4181Amnio wound, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4182Transcyte, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4183Surgigraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4184Cellesta or cellesta duo, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4185Cellesta flowable amnion (25 mg per cc); per 0.5 cc
- Q4186Epifix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4187Epicord, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4188Amnioarmor, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4189Artacent ac, 1 mg
- Q4190Artacent ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4191Restorigin, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4192Restorigin, 1 cc
- Q4193Coll-e-derm, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4194Novachor, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4195Puraply, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4196Puraply am, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4197Puraply xt, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4198Genesis amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4199Cygnus matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4200Skin te, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4201Matrion, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4202Keroxx (2.5g/cc), 1cc
- Q4203Derma-gide, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4204Xwrap, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4205Membrane graft or membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4206Fluid flow or fluid gf, 1 cc
- Q4207Carbon life, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4208Novafix, per square cenitmeter (add-on, list separately in addition to primary procedure)
- Q4209Surgraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4210Axolotl graft or axolotl dualgraft, per square centimeter
- Q4211Amnion bio or axobiomembrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4212Allogen, per cc
- Q4213Ascent, 0.5 mg
- Q4214Cellesta cord, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4215Axolotl ambient or axolotl cryo, 0.1 mg
- Q4216Artacent cord, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4217Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4218Surgicord, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4219Surgigraft-dual, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4220Bellacell hd or surederm, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4221Amniowrap2, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4222Progenamatrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4223Dermabind sl optic, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4224Human health factor 10 amniotic patch (hhf10-p), per square centimeter (add-on, list separately in addition to primary procedure)
- Q4225Amniobind or dermabind tl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4226Myown skin, includes harvesting and preparation procedures, per square centimeter
- Q4227Amniocore, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4228Bionextpatch, per square centimeter
- Q4229Cogenex amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4230Cogenex flowable amnion, per 0.5 cc
- Q4231Corplex p, per cc
- Q4232Corplex, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4233Surfactor or nudyn, per 0.5 cc
- Q4234Xcellerate, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4235Amniorepair or altiply, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4236Carepatch, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4237Cryo-cord, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4238Derm-maxx, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4239Amnio-maxx or amnio-maxx lite, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4240Corecyte, for topical use only, per 0.5 cc
- Q4241Polycyte, for topical use only, per 0.5 cc
- Q4242Amniocyte plus, per 0.5 cc
- Q4243Amchomatrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4244Procenta, per 200 mg
- Q4245Amniotext, per cc
- Q4246Coretext or protext, per cc
- Q4247Amniotext patch, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4248Dermacyte amniotic membrane allograft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4249Amniply, for topical use only, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4250Amnioamp-mp, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4251Vim, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4252Vendaje, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4253Zenith amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4254Novafix dl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4255Reguard, for topical use only, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4256Mlg-complete, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4257Relese, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4258Enverse, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4259Celera dual layer or celera dual membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4260Signature apatch, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4261Tag, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4262Dual layer impax membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4263Surgraft tl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4264Cocoon membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4265Neostim tl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4266Neostim membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4267Neostim dl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4268Surgraft ft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4269Surgraft xt, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4270Complete sl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4271Complete ft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4272Esano a, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4273Esano aaa, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4274Esano ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4275Esano aca, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4276Orion, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4277Woundplus membrane or e-graft, per square centimeter
- Q4278Epieffect, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4279Vendaje ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4280Xcell amnio matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4281Barrera sl or barrera dl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4282Cygnus dual, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4283Biovance tri-layer or biovance 3l, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4284Dermabind sl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4285Nudyn dl or nudyn dl mesh, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4286Nudyn sl or nudyn slw, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4287Dermabind dl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4288Dermabind ch, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4289Revoshield + amniotic barrier, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4290Membrane wrap-hydro, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4291Lamellas xt, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4292Lamellas, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4293Acesso dl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4294Amnio quad-core, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4295Amnio tri-core amniotic, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4296Rebound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4297Emerge matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4298Amniocore pro, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4299Amniocore pro+, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4300Acesso tl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4301Activate matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4302Complete aca, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4303Complete aa, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4304Grafix plus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4305American amnion ac tri-layer, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4306American amnion ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4307American amnion, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4308Sanopellis, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4309Via matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4310Procenta, per 100 mg
- Q4311Acesso, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4312Acesso ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4313Dermabind fm, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4314Reeva ft, per square cenitmeter (add-on, list separately in addition to primary procedure)
- Q4315Regenelink amniotic membrane allograft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4316Amchoplast, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4317Vitograft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4318E-graft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4319Sanograft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4320Pellograft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4321Renograft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4322Caregraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4323Alloply, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4324Amniotx, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4325Acapatch, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4326Woundplus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4327Duoamnion, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4328Most, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4329Singlay, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4330Total, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4331Axolotl graft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4332Axolotl dualgraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4333Ardeograft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4334Amnioplast 1, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4335Amnioplast 2, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4336Artacent c, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4337Artacent trident, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4338Artacent velos, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4339Artacent vericlen, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4340Simpligraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4341Simplimax, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4342Theramend, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4343Dermacyte ac matrix amniotic membrane allograft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4344Tri-membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4345Matrix hd allograft dermis, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4346Shelter dm matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4347Rampart dl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4348Sentry sl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4349Mantle dl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4350Palisade dm matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4351Enclose tl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4352Overlay sl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4353Xceed tl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4354Palingen dual-layer membrane and dual-layer palingen x-membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4355Abiomend xplus membrane and abiomend xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4356Abiomend membrane and abiomend hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4357Xwrap plus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4358Xwrap dual, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4359Choriply, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4360Amchoplast fd, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4361Epixpress, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4362Cygnus disk, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4363Amnio burgeon membrane and hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4364Amnio burgeon xplus membrane and xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4365Amnio burgeon dual-layer membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4366Dual layer amnio burgeon x-membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4367Amniocore sl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4368Amchothick, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4369Amnioplast 3, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4370Aeroguard, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4371Neoguard, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4372Amchoplast excel, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4373Membrane wrap lite, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4375Duograft ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4376Duograft aa, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4377Trigraft ft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4378Renew ft matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4379Amniodefend ft matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4380Advograft one, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4382Advograft dual, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4383Axolotl graft ultra, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4384Axolotl dualgraft ultra, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4385Apollo ft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4386Acesso trifaca, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4387Neothelium ft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4388Neothelium 4l, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4389Neothelium 4l+, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4390Ascendion, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4391Amnioplast double, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4392Grafix duo, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4393Surgraft ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4394Surgraft aca, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4395Acelagraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4396Natalin, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4397Summit aaa, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4398Summit ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4399Summit fx, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4400Polygon3 membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4401Absolv3 membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4402Xwrap 2.0, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4403Xwrap dual plus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4404Xwrap hydro plus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4405Xwrap fenestra plus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4406Xwrap fenestra, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4407Xwrap tribus, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4408Xwrap hydro, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4409Amniomatrixf3x, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4410Amchomatrixdl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4411Amniomatrixf4x, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4412Choriofix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4413Cygnus solo, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4414Simplichor, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4415Alexiguard sl-t, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4416Alexiguard tl-t, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4417Alexiguard dl-t, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4418Biolab membrane wrap flow, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4419Biolab membrane wrap lite flow, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4420Nuform, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4421Biolab membrane wrap solo, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4422A/c wrap, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4423Biolab tri-membrane wrap flow, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4424Revive ft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4425Revive tl, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4426Dermabind tl + or dermabind tl x, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4427Dermabind dl n or dermabind dl + or dermabind dl x, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4428Dermabind sl n or dermabind sl + or dermabind sl x, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4429Dermabind ch n or dermabind ch x, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4431Pma skin substitute product, not otherwise specified (list in addition to primary procedure)
- Q4432510(k) skin substitute product, not otherwise specified (list in addition to primary procedure)
- Q4433361 hct/p skin substitute product, not otherwise specified (list in addition to primary procedure)
- Q4435Renati membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4436Renati ac membrane, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4437Revival ac, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4438Pretect, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4439Instagraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4440Curamatrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q5001Hospice or home health care provided in patient's home/residence
- Q5002Hospice or home health care provided in assisted living facility
- Q5003Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
- Q5004Hospice care provided in skilled nursing facility (snf)
- Q5005Hospice care provided in inpatient hospital
- Q5006Hospice care provided in inpatient hospice facility
- Q5007Hospice care provided in long term care facility
- Q5008Hospice care provided in inpatient psychiatric facility
- Q5009Hospice or home health care provided in place not otherwise specified (nos)
- Q5010Hospice home care provided in a hospice facility
- Q5098Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
- Q5099Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
- Q5100Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg
- Q5101Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
- Q5102Injection, infliximab, biosimilar, 10 mg
- Q5103Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
- Q5104Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
- Q5105Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
- Q5106Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
- Q5107Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
- Q5108Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
- Q5109Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
- Q5110Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
- Q5111Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
- Q5112Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
- Q5113Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
- Q5114Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
- Q5115Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
- Q5116Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
- Q5117Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
- Q5118Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
- Q5119Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
- Q5120Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg
- Q5121Injection, infliximab-axxq, biosimilar, (avsola), 10 mg
- Q5122Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
- Q5123Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
- Q5124Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
- Q5125Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
- Q5126Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
- Q5127Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
- Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
- Q5129Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
- Q5130Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
- Q5131Injection, adalimumab-aacf (idacio), biosimilar, 20 mg
- Q5132Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg
- Q5133Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
- Q5134Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg
- Q5135Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg
- Q5136Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
- Q5137Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg
- Q5138Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg
- Q5139Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg
- Q5140Injection, adalimumab-fkjp, biosimilar, 1 mg
- Q5141Injection, adalimumab-aaty, biosimilar, 1 mg
- Q5142Injection, adalimumab-ryvk biosimilar, 1 mg
- Q5143Injection, adalimumab-adbm, biosimilar, 1 mg
- Q5144Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
- Q5145Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
- Q5146Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg
- Q5147Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg
- Q5148Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
- Q5149Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg
- Q5150Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
- Q5151Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
- Q5152Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg
- Q5153Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg
- Q5154Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
- Q5155Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
- Q5156Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
- Q5157Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg
- Q5158Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg
- Q5159Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
- Q5160Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg
- Q5161Injection, denosumab-kyqq (aukelso/bosaya), biosimilar, 1 mg
- Q5162Injection, denosumab-nxxp (bildyos/bilprevda), biosimilar, 1 mg
- Q5164Injection, ustekinumab-hmny (starjemza), biosimilar, 1 mg
- Q5165Injection, denosumab-mobz (oziltus), biosimilar, 1 mg
- Q5166Injection, denosumab-desu (osvyrti/jubereq), biosimilar, 1 mg
- Q5167Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mg
- Q5168Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg
- Q5169Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg
- Q5170Injection, aflibercept-boav (eydenzelt), biosimilar, 1 mg
- Q5171Injection, denosumab-mobz (boncresa), biosimilar, 1 mg
- Q5172Injection, filgrastim-laha (filkri), biosimilar, 1 microgram
- Q5173Injection, denosumab-adet (ponlimsi), biosimilar, 1 mg
- Q9001Assessment by chaplain services
- Q9002Counseling, individual, by chaplain services
- Q9003Counseling, group, by chaplain services
- Q9004Department of veterans affairs whole health partner services
- Q9950Injection, sulfur hexafluoride lipid microspheres, per ml
- Q9951Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9953Injection, iron-based magnetic resonance contrast agent, per ml
- Q9954Oral magnetic resonance contrast agent, per 100 ml
- Q9955Injection, perflexane lipid microspheres, per ml
- Q9956Injection, octafluoropropane microspheres, per ml
- Q9957Injection, perflutren lipid microspheres, per ml
- Q9958High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
- Q9959High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
- Q9960High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
- Q9961High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
- Q9962High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
- Q9963High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
- Q9964High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9965Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
- Q9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
- Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
- Q9968Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
- Q9969Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
- Q9970Injection, ferric carboxymaltose, 1mg
- Q9972Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- Q9973Injection, epoetin beta, 1 microgram, (non-esrd use)
- Q9974Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- Q9975Injection, factor viii fc fusion protein (recombinant), per iu
- Q9976Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
- Q9977Compounded drug, not otherwise classified
- Q9978Netupitant 300 mg and palonosetron 0.5 mg
- Q9979Injection, alemtuzumab, 1 mg
- Q9980Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
- Q9981Rolapitant, oral, 1 mg
- Q9982Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- Q9983Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Q9984Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
- Q9985Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- Q9986Injection, hydroxyprogesterone caproate, (makena), 10 mg
- Q9987Pathogen(s) test for platelets
- Q9988Platelets, pheresis, pathogen-reduced, each unit
- Q9989Ustekinumab, for intravenous injection, 1 mg
- Q9991Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
- Q9992Injection, buprenorphine extended-release (sublocade), greater than 100 mg
- Q9993Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- Q9994In-line cartridge containing digestive enzyme(s) for enteral feeding, each
- Q9995Injection, emicizumab-kxwh, 0.5 mg
- Q9996Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
- Q9997Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
- Q9998Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
- Q9999Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg